FindTrial
Sign In

Guanfacine (GFC)

DRUG2 trials

Sponsors

Janssen Research & Development, LLC, Johns Hopkins University

Conditions

Attention Deficit Disorder With HyperactivityAutonomic Nervous System DiseasesDysautonomiaOrthostatic IntolerancePostural Orthostatic Tachycardia Syndrome (POTS)

Early Phase 1

Guanfacine and Cromolyn Sodium for POTS: The DBPOTS Trial
Not yet recruitingNCT07757555
Johns Hopkins UniversityPostural Orthostatic Tachycardia Syndrome (POTS), Dysautonomia, Orthostatic Intolerance +1
Start: 2026-08-15End: 2028-02-02Target: 25Updated: 2026-08-12

Unknown Phase

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
CompletedNCT04113551
Janssen Research & Development, LLCAttention Deficit Disorder With Hyperactivity
Start: 2019-10-01End: 2020-01-10Updated: 2025-04-27